Adverse Effects of Antiepileptic Drug Therapies

Epilepsy management relies on antiepileptic drugs (AEDs) to achieve seizure control, yet these therapies can provoke a broad spectrum of adverse effects that impact patient well-being and treatment adherence. Common neurological consequences include sedation, dizziness, cognitive impairment and ataxia, which often emerge during dose escalation or in polytherapy regimens. Systemic reactions span gastrointestinal disturbances, weight fluctuations and dermatological eruptions, while haematological and hepatic toxicity represent more serious, albeit less frequent, complications. Older AEDs such as phenobarbital and phenytoin tend to exhibit a higher incidence of serious outcomes including prolonged hospitalisation, congenital anomalies and life-threatening reactions. Newer agents offer improved tolerability but still carry risks of psychiatric disturbances and idiosyncratic hypersensitivity. The balance between therapeutic efficacy and tolerability remains a major clinical challenge. Identification of patient-specific risk factors—such as comorbidities, seizure frequency prior to treatment and polypharmacy—guides personalised regimens and informs counselling strategies. Robust pharmacovigilance systems and proactive monitoring protocols are essential to detect emerging safety signals, optimise dose adjustments and support patient education to mitigate adverse outcomes.

Research from Nature Portfolio

A prospective observational study conducted at a tertiary centre in Ethiopia evaluated antiseizure adverse drug reactions in 290 ambulatory patients over one year. Using standardised causality assessment, the investigators reported a 33.8 percent prevalence of adverse drug reactions, most frequently with phenobarbital and phenytoin. Epigastric pain and central nervous system drowsiness were the predominant symptoms. Multivariate analysis identified comorbid conditions, seizure-free duration under two years and polytherapy as significant risk factors, underscoring the importance of tailored treatment plans and vigilant follow-up in low-resource settings.

Adverse Effects of Antiepileptic Drug Therapies publication trend

The graph below shows the total number of articles in adverse effects of antiepileptic drug therapies across all publications each year (not limited to Nature Index journals).

Technical terms

Adverse drug reaction (ADR): Unintended and harmful response to a medication administered at normal doses for prophylaxis, diagnosis or therapy.

Monotherapy: Use of a single antiepileptic drug to control seizures, often associated with lower adverse effect burden.

Polytherapy: Concomitant use of two or more antiepileptic drugs, which may enhance efficacy but increases risk of drug interactions and adverse reactions.

Pharmacovigilance: Systematic monitoring of drug safety to detect, assess and prevent adverse effects after market introduction.

System organ class (SOC): Classification of adverse events by affected organ system, facilitating standardised reporting in regulatory databases.

References

1. Seriousness and outcomes of reported adverse drug reactions in old and new antiseizure medications: a pharmacovigilance study using EudraVigilance database. Frontiers in Pharmacology (2024).
2. Antiseizure adverse drug reaction and associated factors among epileptic patients at Jimma Medical Center: a prospective observational study. Scientific Reports (2024).
3. Adverse drug reactions associated with six commonly used antiepileptic drugs in southern China from 2003 to 2015. BMC Pharmacology and Toxicology (2019).